GW Pharmaceuticals Insider ownership
What is the Insider ownership of GW Pharmaceuticals?
The Insider ownership of GW Pharmaceuticals is 0.20%
What is the definition of Insider ownership?
Insider Ownership is calculated as the total number of shares owned by insiders (shareholders who own more than 5% of the corporation or an officer or director of the company) divided by the total Shares Outstanding.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Insider ownership of companies in the Health Care sector on NASDAQ compared to GW Pharmaceuticals
Companies with insider ownership similar to GW Pharmaceuticals
- Diageo plc has Insider ownership of 0.19%
- Galenica AG has Insider ownership of 0.19%
- Octopus Titan VCT has Insider ownership of 0.19%
- Marathon Oil has Insider ownership of 0.19%
- Diageo Plc has Insider ownership of 0.19%
- Diageo Plc has Insider ownership of 0.19%
- GW Pharmaceuticals has Insider ownership of 0.20%
- Humana has Insider ownership of 0.20%
- Liberty All-Star Growth Fund Inc has Insider ownership of 0.20%
- Drone Delivery Canada has Insider ownership of 0.20%
- AMC Entertainment Inc has Insider ownership of 0.20%
- Drone Delivery Canada has Insider ownership of 0.20%
- Cognizant Technology Solutions has Insider ownership of 0.20%